Preferred Label : Ras-associated autoimmune leukoproliferative disorder;
Symbol : RALD;
CISMeF acronym : ALPS4; RALD;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : ALPS4; Autoimmune lymphoproliferative syndrome, type iv;
Description : Autoimmune lymphoproliferative syndromes are characterized by chronic accumulation
of nonmalignant lymphocytes, defective lymphocyte apoptosis, and an increased risk
for the development of hematologic malignancies. ALPS IV is the first form known to
be caused by abnormal intrinsic pathway apoptosis (summary by Oliveira et al., 2007).
For a general phenotypic description and a discussion of genetic heterogeneity of
ALPS, see 601859.;
Inheritance : Autosomal dominant;
Molecular basis : Caused by somatic mutation in the NRAS proto-oncogene, GTPase, gene (NRAS, 164790.0003); Caused by somatic mutation in the KRAS proto-oncogene, GTPase, gene (KRAS, 190070.0005);
Neoplasia : Increased risk of hematologic malignancy (1 patient);
Prefixed ID : #614470;
Origin ID : 614470;
UMLS CUI : C2674723;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)